Although clinical application of anti-TNF-α therapy has not been established in the treatment of human NASH, anti-TNF-α neutralizing antibodies are effectively used to treat various human inflammatory disorders, such as rheumatoid arthritis and inflammatory bowel diseases [6], [7]. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.